QTTB Insider Trading Activity and SEC Form 4 Filings
QTTB insider trading summary
Over the past 12 months, insiders at Q32 Bio Inc. (QTTB) reported 11 sales worth $505K by 3 insiders and 8 open-market purchases worth $60.0M by 4 insiders on SEC Form 4. Net insider buying was $59.5M.
Latest QTTB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Jodie Pope Morrison | CEO | Sell | $27K (3,221 @ $8.32) |
| Oct 6, 2026 | Lee Kalowski | CFO and President | Sell | $11K (1,301 @ $8.32) |
| Oct 6, 2026 | Shelia M. Violette | Chief Scientific Officer | Sell | $8K (917 @ $8.32) |
| Aug 25, 2026 | Lee Kalowski | CFO and President | Sell | $66K (3,972 @ $16.56) |
| Aug 25, 2026 | Shelia M. Violette | Chief Scientific Officer | Sell | $46K (2,798 @ $16.56) |
| Aug 25, 2026 | Jodie Pope Morrison | CEO | Sell | $163K (9,845 @ $16.56) |
| May 28, 2026 | Diyong Xu | Director | Buy | $10.0M (1,250,000 @ $8.00) |
| May 28, 2026 | Orbimed Advisors LLC | Director | Buy | $5.0M (625,000 @ $8.00) |
| May 28, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $10.0M (1,250,000 @ $8.00) |
| May 28, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $5.0M (625,000 @ $8.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.